Halozyme Therapeutics (NasdaqGS:HALO) FY Conference Transcript

Halozyme Therapeutics (NasdaqGS:HALO) FY Conference September 08, 2025 07:45 AM ET Company ParticipantsHelen Torley - President & CEOConference Call ParticipantsSean Laaman - Research Analyst - Biotechnology Small & MidcapSean LaamanGood morning, everyone. Welcome to Morgan Stanley's Global Healthcare Conference. I'm Sean Lam, the Head of the SmidtCap Biotech Equity Research team here at the firm. For important disclosures, please see Morgan Stanley Research Disclosure website at www.morganstanley.com/resea ...